V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20026896 | 20085654 | 1.79 | 63.6 | Curative (C) | 2017-02-09 | 2017-02-12 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101520323 |
| 20026897 | 20085655 | 1.8 | 71 | Neo-adjuvant (N) | 2021-04-20 | 2021-04-21 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100045606 |
| 20026900 | 20085656 | 1.72 | 98.4 | Palliative (P) | 2016-06-08 | 2016-06-26 | Enzalutamide | null | N | CARBOPLATIN | 101461184 |
| 20026925 | 20085657 | 1.55 | 77.4 | Palliative (P) | 2019-01-24 | 2019-02-20 | Enzalutamide | 2 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100883514 |
| 20026976 | 20085658 | 1.66 | 74 | Palliative (P) | 2021-06-06 | 2021-06-20 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100604430 |
| 20027010 | 20085660 | 1.74 | 61.62 | null | 2018-12-15 | 2019-01-16 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100815448 |
| 20027029 | 20085661 | 1.71 | 71.1 | Palliative (P) | 2019-07-05 | 2019-07-22 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100893500 |
| 20027041 | 20085662 | 1.65 | 50.8 | Not known (9) | null | 2018-04-19 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100634075 |
| 20027048 | 20085663 | 1.65 | 51 | Palliative (P) | 2019-03-24 | 2019-03-24 | OCTREOTIDE | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101220154 |
| 20027056 | 20085664 | 1.65 | 72.9 | Palliative (P) | 2017-12-26 | 2018-01-08 | Cetuximab 14 day | 02 | N | CARBOPLATIN | 101312079 |
| 20027204 | 20085665 | 1.74 | null | Curative (C) | 2016-11-04 | 2016-11-11 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100131731 |
| 20027248 | 20085666 | 1.8 | 94 | Palliative (P) | 2022-03-23 | 2022-04-16 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101162594 |
| 20027278 | 20085667 | 1.56 | 104 | Palliative (P) | 2016-05-31 | 2016-06-01 | Enzalutamide | 02 | N | MITOMYCIN INTRAVESICULAR | 100900697 |
| 20027301 | 20085668 | 1.71 | 58.3 | Palliative (P) | 2017-11-11 | 2017-11-30 | Enzalutamide | N | N | CAPECITABINE + TEMOZOLOMIDE | 100932791 |
| 20027326 | 20085669 | 1.68 | 75 | null | 2018-09-21 | 2018-09-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101442035 |
| 20027336 | 20085670 | 1.8 | 69 | Palliative (P) | 2019-02-18 | 2019-02-18 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101039872 |
| 20027355 | 20085672 | 1.6 | 73.8 | Curative (C) | 2018-04-05 | 2018-04-05 | Capecitabine + Cisplatin + RT | 99 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101058479 |
| 20027367 | 20085673 | 1.58 | 148.7 | Palliative (P) | 2016-10-22 | 2016-10-22 | Enzalutamide | 02 | N | CETUXIMAB | 101134959 |
| 20027393 | 20085674 | 1.65 | 96.6 | Palliative (P) | 2019-03-02 | 2019-03-02 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101534294 |
| 20027409 | 20085675 | 1.58 | 57.2 | 03 | 2019-11-02 | 2019-11-18 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100604729 |
| 20027414 | 20085676 | 1.86 | 97 | Adjuvant (A) | 2020-09-28 | 2020-10-07 | Enzalutamide | 02 | null | CISPLATIN | 100215552 |
| 20027464 | 20085677 | 1.6 | 50.9 | null | 2019-08-02 | 2019-08-02 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101105047 |
| 20027520 | 20085678 | 1.6 | 64 | Palliative (P) | 2019-05-21 | 2019-05-27 | OCTREOTIDE | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100975793 |
| 20027529 | 20085679 | 1.6 | 90 | Curative (C) | null | 2019-07-12 | Capecitabine + Cisplatin + RT | null | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100123364 |
| 20027568 | 20085680 | 1.65 | 88.9 | Neo-adjuvant (N) | 2015-09-10 | 2015-09-10 | Enzalutamide | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100401202 |
| 20027630 | 20085682 | 1.69 | 87.7 | Curative (C) | 2021-08-27 | 2021-09-10 | Enzalutamide | 02 | N | CARBOPLATIN | 100371024 |
| 20027656 | 20085683 | 1.51 | 69.3 | Palliative (P) | 2018-08-09 | 2018-08-16 | Enzalutamide | 1 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100779015 |
| 20027660 | 20085684 | 1.74 | 91.5 | Palliative (P) | 2018-09-08 | 2018-09-22 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100406404 |
| 20027707 | 20085685 | 1.59 | 68.3 | Curative (C) | 2020-01-26 | 2020-02-01 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101053851 |
| 20027731 | 20085686 | 1.6 | 46.4 | 03 | 2019-12-10 | 2019-12-11 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | ENZALUTAMIDE | 100509596 |
| 20027753 | 20085687 | 1.65 | 79.45 | null | 2016-08-24 | 2016-09-04 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101810360 |
| 20027810 | 20085689 | 1.73 | 78 | Palliative (P) | 2019-12-16 | 2019-12-22 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100425924 |
| 20027882 | 20085690 | null | null | null | 2017-01-30 | 2017-01-31 | Enzalutamide | 02 | null | SCALOP-2 TRIAL | 101688549 |
| 20027910 | 20085691 | 1.91 | 79.7 | Neo-adjuvant (N) | 2017-01-13 | 2017-01-26 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | CETUXIMAB + OXALIPLATIN + MDG | 101186814 |
| 20027986 | 20085692 | null | 62.6 | Palliative (P) | 2016-03-17 | 2016-04-01 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101257270 |
| 20028008 | 20085693 | 0 | 0 | null | 2019-05-11 | 2019-05-15 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101441680 |
| 20028031 | 20085694 | 1.76 | 60 | Curative (C) | 2018-07-07 | 2018-07-08 | Enzalutamide | 02 | Y | TRASTUZUMAB | 101591777 |
| 20028042 | 20085695 | 0 | 0 | Palliative (P) | 2019-03-21 | 2019-03-22 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101208479 |
| 20028081 | 20085696 | 1.5 | 71.6 | Palliative (P) | 2018-11-17 | 2018-11-24 | Enzalutamide | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100429711 |
| 20028102 | 20085697 | 1.66 | 85.3 | Palliative (P) | 2020-02-26 | 2020-03-05 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100740872 |
| 20028136 | 20085698 | 1.72 | 101 | Curative (C) | 2019-12-16 | 2019-12-26 | Enzalutamide | N | N | CETUXIMAB | 101345169 |
| 20028137 | 20085699 | 1.53 | 60.8 | Neo-adjuvant (N) | 2019-10-16 | 2019-10-23 | ECF | 2 | Y | TRASTUZUMAB | 100703498 |
| 20028153 | 20085700 | 1.51 | 129 | null | 2018-02-21 | 2018-02-22 | CAPECITABINE + TEMOZOLOMIDE | 02 | Y | CAPECITABINE + TEMOZOLOMIDE | 100014075 |
| 20028178 | 20085701 | 1.52 | 87.3 | 02 | 2021-01-03 | 2021-01-10 | Cetuximab 14 day | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 100560061 |
| 20028186 | 20085702 | 1.66 | 0 | Curative (C) | 2018-04-10 | 2018-04-16 | Enzalutamide | 2 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101666236 |
| 20028191 | 20085703 | null | 73.7 | null | 2017-04-30 | 2017-05-19 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100458470 |
| 20028238 | 20085704 | 1.61 | 75.3 | Palliative (P) | null | 2017-04-28 | Trastuzumab | N | N | TRASTUZUMAB | 100732678 |
| 20028275 | 20085705 | 1.62 | 56.9 | Curative (C) | 2018-08-11 | 2018-08-19 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101068933 |
| 20028349 | 20085706 | null | 64.6 | Palliative (P) | 2019-09-04 | 2019-09-08 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100249156 |
| 20028380 | 20085707 | 1.73 | null | Palliative (P) | 2019-01-30 | 2019-01-30 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100757730 |